IBEX director granted 2,083 restricted stock units

Batungbacal Karen reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Batungbacal Karen reported acquisition or exercise transactions in this Form 4 filing.

IBEX Ltd director Karen Batungbacal reported an equity award of 2,083 common-share-based restricted stock units (RSUs). Each RSU represents the right to receive one common share. According to the vesting schedule, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on each of the next three yearly anniversaries, as long as she remains in continuous service with the company.

Insider Trade Summary

Grant/Award: 2,083 shares

Grant/Award 1 txn

Insider Batungbacal Karen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	2,083	$0.00	$0.00

Holdings After Transaction: Common Shares — 7,083 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for Karen Batungbacal?

IBEX reported that director Karen Batungbacal received a grant of 2,083 restricted stock units tied to common shares. These RSUs represent rights to receive shares over time, subject to a multi-year vesting schedule tied to her continued service with the company.

How many IBEX shares are involved in Karen Batungbacal’s Form 4 filing?

The Form 4 shows Karen Batungbacal was granted 2,083 restricted stock units linked to IBEX common shares. Each RSU converts into one share upon vesting, creating a potential future issuance of 2,083 shares if all vesting conditions are satisfied.

What is the vesting schedule for Karen Batungbacal’s IBEX RSU grant?

The RSU grant vests over four years. Twenty-five percent of the 2,083 restricted stock units vest on July 1, 2026, with 25% vesting on each of the following three years’ anniversaries, provided she remains in continuous service on every vesting date.

What does Karen Batungbacal’s RSU grant at IBEX represent for shareholders?

The grant represents a potential future issuance of 2,083 IBEX common shares to director Karen Batungbacal. Shares are not issued immediately; they are delivered only as RSUs vest over four years, contingent on her continued service with the company.

Did Karen Batungbacal buy or sell IBEX shares in this Form 4?

The Form 4 reflects an acquisition via an equity award, not a market purchase or sale. Karen Batungbacal received 2,083 restricted stock units as a grant, with future share delivery dependent on satisfying the time-based vesting conditions described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:06 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Batungbacal Karen

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/02/2026		A		2,083(1)	A	$0(1)	7,083	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.